• Earlier this month, Bath & Body Works entered Brazil through its first store and digital platform, tailoring its fragrance assortment to local preferences for fruity and tropical scents while extending its Viva collection inspired by Brazilian culture.
• This move adds Brazil to the company’s more than 550 international locations across six continents and over 45 countries, underscoring how its franchise-partner model and localized product curation underpin its global expansion approach.
• Next, we’ll explore how expanding into Brazil through a localized assortment could influence Bath & Body Works’ investment narrative and growth levers.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Bath & Body Works Investment Narrative Recap

To own Bath & Body Works, you need to believe its brand strength and fragrance innovation can offset recent revenue pressure and a heavy store base. The Brazil entry fits the long term international expansion catalyst, but it is unlikely to be the main near term share price driver compared with execution on digital upgrades and stabilizing margins, while elevated debt and negative equity remain a key risk that could constrain flexibility if trends disappoint.

The launch of the Fruit Fusion body care franchise is especially relevant here. It reinforces the product innovation catalyst by leaning into wellness style hydration claims and vegan formulas, while still playing to the brand’s core strength in fragrance newness. How Fruit Fusion performs, alongside localized launches such as Brazil’s Viva collection, will be an early test of whether new concepts can support traffic and pricing without deepening the reliance on promotions.

Yet beneath the expansion headlines, investors should also be aware of the risk that rising operating and sustainability costs could pressure margins if...

Bath & Body Works' narrative projects $7.6 billion revenue and $708.4 million earnings by 2029. This requires 1.5% yearly revenue growth and a $18.6 million earnings decrease from $727.0 million today.

Uncover how Bath & Body Works' forecasts yield a $25.64 fair value, a 23% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts take a much more cautious view, assuming revenue stays near US$7.4 billion and earnings slip toward US$600 million, so when you set that against Brazil and new franchises, you can see how opinions on Bath & Body Works differ widely and why it is worth exploring several alternative viewpoints before you decide what you believe.

Explore 7 other fair value estimates on Bath & Body Works - why the stock might be worth as much as 78% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Bath & Body Works research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Bath & Body Works research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bath & Body Works' overall financial health at a glance.

Ready For A Different Approach?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Find 47 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.